Latest Developments & Updates in Covid-19 Bedside Therapeutics

Covid-19 and Comorbidities: Association & Complications Latest Developments & Updates in Covid-19 Therapeutics Novel Covid-19 Clinical Case Reports

Proudly supported by

Meet our Speakers

We've gathered some of the top experts in the field to discuss this topic. With years of experience between them, they're well-equipped to offer invaluable insights and perspectives.

Dr Tibor Bakács

Dr Tibor Bakács

Hungarian Academy of Sciences & HepC Inc, Hungary

Prof. James Cai

Prof. James Cai

Texas A&M University, USA

Dr Bruna Corradetti

Dr Bruna Corradetti

Houston Methodist Research Institute, USA.

Prof. Antonio Facchiano

Prof. Antonio Facchiano

Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy

Prof. Rafael Franco

Prof. Rafael Franco

Universidad de Barcelona. Barcelona, Spain

Dr Delia Goletti

Dr Delia Goletti

National Institute for Infectious Disease L. Spallanzani, Rome, Italy

Dr Dicky L. Tahapary

Dr Dicky L. Tahapary

Faculty of Medicine Universitas Indonesia (RSCM-FKUI), Indonesia

Prof. Eleftherios Mylonakis

Prof. Eleftherios Mylonakis

Alpert Medical School of Brown University, Rhode Island Hospital & The Miriam Hospital, USA

Prof. Sean P. J. Whelan

Prof. Sean P. J. Whelan

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, USA

Prof. Maurizio Salvadori

Prof. Maurizio Salvadori

Department of Nephrology and Transplantation, University of Florence, Florence, Italy

Prof. Mikhail Sheianov

Prof. Mikhail Sheianov

Burnasyan Federal Medical Biophysical Center,Moscow, Russia

Prof. A. Ozlem Tastan Bishop

Prof. A. Ozlem Tastan Bishop

Department of Biochemistry and Microbiology, Rhodes University, South Africa

Dr Jeremy W Prokop

Dr Jeremy W Prokop

Department of Pharmacology & Toxicology, Michigan State University, Grand Rapids, USA

Eduardo Almeida Soares

Eduardo Almeida Soares

Lancaster University, UK

Dr Salman Mansoor

Dr Salman Mansoor

Sligo University Hospital, Ireland

Dr Corrado Pelaia

Dr Corrado Pelaia

University “Magna Græcia” of Catanzaro, Italy

Talks

Spatiotemporal analysis of micro-epidemics of influenza and COVID-19

21 September 2020, 09:00 AM
Prof. Eleftherios Mylonakis

SARS-CoV-2 mechanisms of severe outcomes

21 September 2020, 12:00 PM
Dr Jeremy W Prokop

Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications

21 September 2020, 01:00 PM
Dr Corrado Pelaia

Baricitinib as a potential drug for COVID-19: evidence from a multicenter trial and translational research studies

21 September 2020, 02:00 PM
Dr Delia Goletti

Allosteric site of SARS-CoV-2 main protease as drug target in the presence of its emerging mutations

21 September 2020, 04:00 PM
Prof. A. Ozlem Tastan Bishop

Stem cells from gestational tissues: a promising tool to restore the body’s own potential to fight SARS-CoV-2 infections

22 September 2020, 02:00 PM
Dr Bruna Corradetti

The renin angiotensin system (RAS) involvement in SARS-CoV-2 infection

23 September 2020, 08:30 AM
Prof. Rafael Franco

Molecular basis of COVID-19 comorbidities

23 September 2020, 10:00 AM
Prof. Antonio Facchiano

Poster Talk: Explainable approach for COVID-19 identification via CT-Scans

23 September 2020, 04:30 PM
Eduardo Almeida Soares

Vesicular stomatitis virus vectored vaccine for SARS-CoV-2

24 September 2020, 08:00 AM
Prof. Sean P. J. Whelan

Pulse Therapy with Corticosteroids and Intravenous Immunoglobulin in the Management of Severe COVID-19. Unusual Treatment with Intriguing Results

24 September 2020, 10:00 AM
Prof. Mikhail Sheianov

Weighing The Impact of Obesity on COVID-19 in Low- to Middle-Income Countries

24 September 2020, 04:00 PM
Dr Dicky L. Tahapary

Poster Talk: The use of Computational Docking to estimate the effects of Montelukast on potential viral main protease catalytic site

24 September 2020, 04:30 PM
Dr Salman Mansoor

SARS-CoV-2 Associated Nephropathy in the Pandemic Era

25 September 2020, 10:00 AM
Prof. Maurizio Salvadori

Machine learning analysis of single-cell gene regulatory networks reveals potential mechanisms of action of antimalarials against SARS-CoV-2

25 September 2020, 12:00 PM
Prof. James Cai

The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections

25 September 2020, 02:00 PM
Dr Tibor Bakács